Company Objectives To apply Biomedical
Engineering to provide significant improvements in the
practice of clinical measurement and associated
therapy, for benefit to the patient, clinician and
healthcare provider.
Overview Neomedix Systems Pty. Ltd.
(NMS) - is a privately held Australian
'BioTechnology' company focused upon the development and
clinical application of diagnostic/therapeutic devices.
The company was formed in 1977 following the purchase of
the business of Devices Pty Ltd from Johnson &
Johnson. The current CEO of NMS, Tony Wynter also
founded Devices Pty Ltd. Unlike most
manufacturing businesses in the medical industry, NMS
has for 15 years previous, been a successful
importer/distributor of sophisticated Life Science and
Clinical diagnostic equipment, including high end
bedside patient monitoring and cardiac investigation
products from Marquette Electronics Inc. (now
GE Medical). Other manufacturers represented
included Nicolet Biomedical (neurophysiology),
Sensormedics Inc. and Medical Graphics
Corp. (respiratory medicine) and two market leading
implantable cardiac pacemaker manufacturers over this
period. In the early 1980s, NMS commenced successful
develop and manufacture of its own products which now
dominate the Australasian market. These products are
used for pre and post operative clinical assessment in
Urogynaecology, Urology, Gastroenterology and Colorectal
investigation. The company can demonstrate extensive
experience in successful medical product development and
in providing sales, marketing and end user clinical
applications support.
|
Current Activity NMS is the manufacturer of
the Acquidata computerised clinical
diagnostic products which it sells, markets and
supports directly in Australia and New Zealand.
Acquidata products have been sold to clinical
sites in Europe and the USA, although generally as a
result of interest following international
exhibitions. Activity is being undertaken to address
expansion of international sales through the
appointment of exclusive distributors in both Europe
and the USA. Two years of cross development has
been completed (mid 2003) and the Acquidata
products are now available for both Apple
Macintosh (OS9 & OSX) and Microsoft
Windows (2000 & XP) platforms. The products have
several unique features. There is also ongoing
enhancement of this product. Development is being
undertaken with new techniques to meet the specific
needs now emerging in urogynaecology brought about
by the increasing surgical adoption of then newer
sub urethral sling procedures such as TVT
(Johnson & Johnson) and IVS (Tyco
Heatlhcare). NMS currently also acts as the
distributor for two USA based clinical and research
'gold standard' equipment manufacturers:
Transonic Systems Inc: a manufacturer of high
accuracy peri-vascular and extracorporeal blood flow
monitoring products and AEI: manufacturer of
medical gas analyzers and metabolic monitors for
pulmonary function investigation and exercise
performance evaluation.
Partnering Opportunities NMS is a
privately owned Biotechnology SME and is interested
in forming on-going strategic relationships with
both its core Acquidata activity and perhaps
separately for the opportunities presented by
product development for the Intensive (or Critical)
Care Unit markets. See Product Development ICU/OR
|
